Comparing two treatment plans for brain tumors that grow after focused radiation
Original title: REMASTer: REcurrent Brain Metastases After SRS Trial
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This study does not list a phase, so we cannot say how far along it is.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial compares two ways to treat brain tumors that spread from cancer and then grow after focused radiation.
Who this trial is for. This trial is for people with brain metastases, which is cancer that spread to the brain. Their scans show growth after focused radiation called stereotactic radiosurgery: Radiation aimed at a small target, in one visit or a few. There is no cutting, despite the name. See the glossary, with or without surgery. The trial compares two different sets of treatment plans at the first treatment for that growth.
Where it stands. This trial has not reported results. It is measuring how well each of the two treatment plans works. The answer is not in yet.
What this means, and what it doesn't
What it could mean: If your brain tumor grew after focused radiation, this trial looks at what to try next. Someone in that spot could ask their care team about it. The care team can say if it fits.
What it doesn't mean: A trial is a test, not a proven treatment. Being in one does not mean you will do better. It is not a promise of a cure. The trial team decides who can join.
Source: ClinicalTrials.gov, October 20, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.